The Respiratory System

at a Glance

Jeremy Ward, Jane Ward and Richard Leach

Case Studies

Case 6

Three men have been admitted with progressive breathlessness and all have an initial arterial PaO2 of 6.6 kPa when breathing air. The first patient is grossly obese and is complaining of a sore throat and an upper respiratory tract infection but has a normal chest CXR. Investigation has excluded pulmonary embolism. The second patient with non-specific interstitial pneumonitis has a reduced gas transfer (i.e. mainly diffusion defect), is on treatment with steroids and has developed a mild lower respiratory tract infection. The third patient has a true right-to-left shunt due to a longstanding atrial septal defect, and apart from a slightly enlarged heart has a normal CXR. Each patient is to be treated with oxygen.

  • 1. Why is each patient hypoxaemic and what will happen when the FiO2 is raised to 1.0 (i.e. 100% oxygen therapy)? Precise answers cannot be calculated but assume reasonable values for unknown data.

    Correct answer:
    Patient 1:
    This patient has a mild upper respiratory tract infection and no significant low respiratory tract pathology. However, he is probably hypoventilating due to gross obesity restricting normal respiratory movement. Assuming his gas transfer and V/Q matching are normal, his PaCO2 can be calculated from the alveolar gas equation (Chapter 14):

    PAO2=PIO2
    PaCO2 / R

    where PAO2≈PaO2 = 6.6 kPa (as measured); PIO2 = FiO2 × (barometric − water vapour pressure) = 0.21 × (101 − 6.2) = 19.9 kPa breathing air, and R, the respiratory quotient, is ~0.8. Thus, PaCO2 = 10.6 kPa and if the arterial blood gas measurement confirms this, the patient has type 2 respiratory failure (Chapter 23). If the measured aCO2 was much lower, it would suggest the assumptions were wrong and that another mechanism was causing or contributing to his respiratory failure.
    When the patient is given 100% O2 (FiO2 1.0):
    PIO2=FiO2 × (barometric – water vapour pressure)
    =1 × (101–6.2)=95kPa
    So:
    PaO2 ≈ PAO2 = 95 –
    10.6 / 0.8
    =82kPa

    Patient 2
    This patient has a diffusion defect due to the interstitial lung disease (ILD, Chapter 30) although usually there is a significant contribution of ventilation/perfusion (V/Q) mismatch due to the hypoxaemia. His PAO2 is thus greater than his PaO2. Arterial blood gas (ABG) shows his PaCO2 is low (4 kPa). The substantial increase in PAO2 when this patient is given 100% oxygen (FiO2 = 1) will more than overcome the partial diffusion defect associated with the ILD, and if this were a pure diffusion defect the PaO2 could approach 90 kPa.

    PaO2 = 95 –
    4 / 0.8
    =90kPa

    Even allowing for a wider than normal range of V/Q ratios in this patient, there would still be a substantial increase in PaO2 on 100% oxygen.

    Figure 49 Effect of true shunt (QS/QT) on the arterial oxygen tension (PaO2) response to inspired oxygen fraction (FiO2).

    Hypoxaemia caused by true right–to–left shunt is refractory to supplemental O2 when ‘shunt fraction’ exceeds 30%.

    Patient 3
    This patient is hypoxaemic due to true right–to–left shunting causing admixture of venous blood to systemic arterial blood (Chapter 13). As in the second case, the PAO2 will be 90 kPa with an FiO2 of 1.0. However, the saturation is already 100% in oxygenated blood passing through the lungs, and O2 content will not be substantially increased by the high PAO2 apart from the small quantity of O2 dissolved in blood (90 × 0.023 mL; Chapter 8). The blood shunted from right to left through the atrial septal defect remains unaffected by the increased PAO2 and acts as venous admixture lowering oxygenation in the systemic circulation. Consequently, an FiO2 of 1.0 only fractionally increases systemic PaO2 perhaps to ~7.5 kPa in this case.

  • 2. How will you ensure improved oxygenation in each patient?

    Correct answer:

    Patient 1
    In some patients with chronic type 2 respiratory failure hypoxia drives ventilation rather than PaO2. As the patient’s PaO2 rises when he is given 100% O2, the drive to breath decreases, and this can lead to a further increase in PaCO2, progressive respiratory acidosis, confusion, coma and death. Consequently, this patient should be managed with low–dose (24–28%) O2 therapy aiming for a saturation of 88–92% and regular measurement of arterial blood gases (Chapters 23 and 43). In this patient optimal treatment to improve oxygenation and reduce CO2 retention would be non–invasive ventilation, which would improve ventilation and alveolar gas exchange (Chapter 42).

    Patient 2
    In this patient simply increasing the inspired oxygen concentration (FiO2 ~ 0.4–0.6) will correct the hypoxaemia. This patient probably has type 1 respiratory failure (Chapter 23) because CO2 diffuses 20 times better than O2 and consequently the diffusion defect does not impair CO2 clearance. The hypoxaemia will cause hyperventilation, and the associated increase in minute ventilation ensures a low PaCO2 (∝ 1/alveolar ventilation). Consequently, there is little risk of hypercapnia during the use of high O2 concentrations in this patient.

    Patient 3
    Only Patient 3 will not show a substantial increase in PaO2 when given 100% O2. In this case oxygenation will only be improved by decreasing the shunt fraction and reducing left–sided venous admixture. Figure 47 illustrates the effect of true shunt on the response to increasing FiO2.

Print Case | « Previous Case | Next Case »